Healthcare

Meet your Healthcare Research team

Uniphar

H1 results reflect sharp acceleration in EPS growth

Uniphar grew its EPS by 21% in H1 2025. This is the company’s fastest rate of growth in several years and is driven by organic gross profit growth, accretion from its share buyback...

Malin Corporation

H1 results

Malin has reported its interim results to June 30th, showing an intrinsic equity value of €9.52/share. This has reduced slightly to €9.45/share at August 25th. This follows the €150m...

Uniphar

H1 2025 trading statement drives further upgrades

Uniphar has issued a trading statement ahead of its H1 2025 results, which will be published on September 2nd. All divisions are performing strongly with c.8% organic gross profit growth....

CVS Group

FY2025 trading statement is in line with expectations

CVS has issued a trading statement for FY2025 to June 30th. Revenues are close to our forecast and were impacted by weak market conditions in the UK. EBITDA is in line with our...

hVIVO

H1 trading statement

hVIVO has issued a trading statement for H1, reiterating FY2025 revenue guidance and indicating a slight improvement in the outlook for EBITDA. The sector remains challenged due to...

hVIVO

Trading update

hVIVO has announced that it has received notification of a significant contract cancellation alongside a postponement and a cancellation of a smaller study. This is due to uncertainty in...

Uniphar

AGM statement

Uniphar will have its AGM later this morning. Ahead of that, the company has confirmed that its capex programmes remain on track, it has reiterated its medium-term EBITDA target,...

CVS Group

CMA working paper on remedies

The Competition and Markets Authority (CMA) has published its working paper on remedies, which primarily focuses on improving disclosure in the market. There is the potential for some...

CVS Group

Disposal of crematoria division

After receiving an attractive offer of 10x EV/EBITDA for its crematoria division, CVS has announced its disposal for £42.4m. The capital will be recycled into further acquisitions in...

hVIVO

FY2024 results

hVIVO has published its FY2024 results. It provided the key figures for 2024 and guidance on 2025 in its January trading statement. 2024 was a record year for the company in terms of...